There is much debate as to whether lymphadenectomy in patients with ovarian cancer is of therapeutic value. In this study the patients with Stage 3 disease and who had a lymphadenectomy performed had a better 5-year survival rate of 38% compared to 22% in the group who did not have a ...
Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20(6):945–52. https://doi.org/10.1111/IGC.0b013e3181dd0110. Article PubMed Google Scholar Bamias A, Sotiropoulou M, Zagouri F, Trachana P, Sakellariou...
I was diagnosed with late 3 or 4th stage ovarian cancer in 1992 metasized to the colon, cavity and diaphram. Since then I have had 5 operations, an autologous stem cell transplant, two liver resections for the cancer when it spread to my liver and 5 different rounds of chemo. However,...
A significant increase in 5-year survival rate was found in the intermittent chemotherapy group when compared with the control group. Side effects from the intermittent chemotherapy were controllable. Intermittent CDDP therapy seems to be an effective consolidation therapy for stage-III ovarian cancer ...
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. A previous dose-escalation trial of the vascular disrupting agent combretastatin A4 phosphate (CA4P) given before carboplatin, paclitaxel, or both showed r... M Zweifel,GC Ja...
aOvarian cancer has one of the highest mortality rates of all gynecologic malignant tumors. More than 70% of patients are late-stage at diagnosis [1], and the 5-year survival rate is approximately 19~40% [2-3]. Locoregional recurrence and distant metastases are ominous events in patients wi...
In advanced gastric cancer patients treated mainly with 5-FU or cisplatin-based chemotherapy, lower expression of EGFR mRNA than the cutoff value was a strong predictor of poor survival by multivariate analysis (Matsubara et al, 2008a). Interestingly, the authors also showed that high DPD and ...
Given that this patient’s tumor was poorly differentiated (grade 3(Javadi et al., 2016), despite stage Ia, she received 6 cycles of Carbo/Taxol. The survival rate of women with stage I epithelial ovarian cancer is 92% (versus 17–28% in advanced stages) (Doubeni et al., 2016), ...
Since ovarian cancer patients did not uniformly undergo comprehensive surgical staging, an occult disease higher than the indicated stage cannot be ruled out. The control group has no known history of cancer, autoimmune diseases, or neurodegenerative disorders, nor any presence of diabetes mellitus (...
Between January 2001 and December 2006, 55 patients with stage III – IV ovarian cancer underwent diagnostic laparoscopy. Primary surgery was performed when complete cytoreduction was considered feasible, while the other patients received neoadjuvant che